Twist Bioscience Corporation
US ˙ NasdaqGS ˙ US90184D1000

SecurityTWST / Twist Bioscience Corporation
InstitutionMercer Global Advisors Inc /adv
Latest Disclosed Ownership5,804 shares
Latest Disclosed Value $ 275,806
Mercer Global Advisors Inc /adv reports 23.82% decrease in ownership of TWST / Twist Bioscience Corporation

On May 15, 2026 - Mercer Global Advisors Inc /adv filed a 13F-HR form disclosing ownership of 5,804 shares of Twist Bioscience Corporation (US:TWST) valued at $275,806 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 7,619 shares of Twist Bioscience Corporation. This represents a change in shares of -23.82% during the quarter. The current value of the position is $401,753 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TWIST BIOSCIENCE COM 90184D100 5,804 -1,815 -23.82 276 14.11 0.0004
2026-02-17 2025-12-31 13F TWIST BIOSCIENCE COM 90184D100 7,619 7,619 242 0.0004
2025-11-14 2025-09-30 13F TWIST BIOSCIENCE COM 90184D100 0 -7,863 -100.00 0 -100.00
2025-08-14 2025-06-30 13F TWIST BIOSCIENCE COM 90184D100 7,863 -5,621 -41.69 289 -45.37 0.0006
2025-05-15 2025-03-31 13F TWIST BIOSCIENCE COM 90184D100 13,484 640 4.98 529 -11.24 0.0012
2025-02-14 2024-12-31 13F TWIST BIOSCIENCE COM 90184D100 12,844 -3,966 -23.59 597 -18.24 0.0015
2024-11-14 2024-09-30 13F TWIST BIOSCIENCE COM 90184D100 16,810 -12,089 -41.83 730 -48.81 0.0017
2024-08-12 2024-06-30 13F TWIST BIOSCIENCE COM 90184D100 28,899 3,752 14.92 1,424 0.0039
2024-05-15 2024-03-31 13F TWIST BIOSCIENCE COM 90184D100 25,147 -872 -3.35 1 0.0025
2024-02-15 2023-12-31 13F TWIST BIOSCIENCE COM 90184D100 26,019 3,719 16.68 1 0.0029
2023-11-15 2023-09-30 13F/A-1 TWIST BIOSCIENCE COM 90184D100 22,300 11,655 109.49 0 0.0017
2023-11-14 2023-09-30 13F TWIST BIOSCIENCE COM 90184D100 22,300 11,655 0 0.0017
2023-08-14 2023-06-30 13F TWILIO CLASS A COMMON STOCK 90184D100 10,645 10,645 0 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.